GRAL Stock Analysis: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$68.56
-2.58 (-3.63%)
▼
5d:
+1.06%
30d:
+0.66%
90d:
+25.84%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
2d
Smart Money Accumulation
None View Scanner →
Strength: 5.6/10
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $68.56, which is considered fair relative to its 30-day fair value range of $66.45 to $72.46.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $62.09, while resistance sits at $73.53. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GRAL is in a strong uptrend. Immediate support is located at $62.09, while resistance sits at $73.53. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$66.45 -
$72.46
Company Quality Score
51/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- NEUTRAL: Near Wall St target ($70.12)
Trading Range Analysis
30-Day Trading Range
$66.45 -
$72.46
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$7.37
(10.8%)
Support & Resistance Levels
Support Level
$62.09
Resistance Level
$73.53
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.06
Wall Street Target
$70.13
(+2.3%)
Revenue Growth (YoY)
28.1%
Profit Margin
-253.2%
Share & Embed Analysis
Last updated: August 02, 2026 8:53 AM ET
Data refreshes hourly during market hours. Next update: 9:53 AM
Data refreshes hourly during market hours. Next update: 9:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman
SELL
61665 shares
2026-04-08
Robert P Ragusa
SELL
123502 shares
2026-04-08
Aaron Freidin
SELL
45806 shares
2026-04-08
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$615 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$171 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
